The Cardio Risk Check is a test panel that typically assesses cardiovascular risk factors such as blood lipids (cholesterol, triglycerides), inflammatory markers (hs-CRP), and often includes fasting glucose or HbA1c. Elevated blood sugar is a well-established risk factor for cardiovascular disease, so including glucose measurement is clinically sensible. However, the Cardio Risk Check is not a substitute for formal diabetes diagnostics. It can provide an initial indication of risk, but for diagnosing impaired glucose tolerance or diabetes, additional tests like an oral glucose tolerance test or continuous glucose monitoring are required. The evidence supporting such checks lies in early risk detection, but fasting glucose alone has lower sensitivity than HbA1c. Moreover, the reliability depends on proper test conditions (fasting?) and individual factors. In summary, the Cardio Risk Check can offer a preliminary glimpse into blood sugar status, but it should not replace a physician's evaluation for diabetes. The evidence is practice-based, not backed by specific studies for this particular test panel.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-69b4e45367484cf2b6ab3545